DraftKings closed up 10% on Friday, its first day of trading after its $3.3B merger with sports betting platform SBTech and Diamond Eagle Acquisition Corp.
Noah Manskar / New York Post :
Context & Ripple Effects
DraftKings' public debut closes out a deal flagged in December, when it announced plans to go public through a reverse merger with a special purpose acquisition company rather than a traditional IPO, folding in sports betting tech platform SBTech at a $3.3B target valuation.
The listing caps a long private run: DraftKings raised $300M at over a $1.2B valuation back in 2015 with Fox Sports leading and committing ad spend, then took another $100M round in 2017 while rival FanDuel raised alongside it. The 10% first-day pop suggests public investors are paying up for exposure to legalized US sports betting.
First-order effects
- DraftKings gains a public currency and balance sheet while holding both a consumer brand and SBTech's B2B betting technology under one listed company.
- FanDuel, which was raising capital in parallel back in 2017, now faces a publicly funded competitor with stock it can use for deals and talent.
Second-order effects
- A clean first-day close on a SPAC route gives other private sports betting and gaming companies a template for going public without an IPO roadshow, pressuring bankers and exchanges that price traditional listings.
- SBTech's technology stack becomes a selling point to other operators and state lotteries, turning what was a private asset into a revenue line visible to public-market scrutiny.
Third-order effects
- If the pattern holds, SPAC reverse mergers become a standard fast lane to public markets for regulated-gaming companies, reshaping how the sector raises capital as legalization spreads state by state.
- Public-listing disclosure requirements could push consolidation among daily fantasy and betting operators, since scale across states becomes something shareholders can directly reward.
The trend: US sports betting operators are reaching public markets through SPAC mergers instead of IPOs, converting regulatory expansion into tradable equity faster than the traditional listing process allows.